Histone-acetylation: A link between Alzheimer's disease and post-traumatic stress disorder?

Frontiers in Neuroscience

Volumn , Issue 8 JUN, 2014, Pages

  Bahari Javan, Sanaz ^a,b   Sananbenesi, Farahnaz ^b   Fischer, Andre ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Alzheimer's disease (AD); Epigenetic gene expression; HDAC inhibitors (HDACi); Histone deacetylases (HDACs); Post traumatic stress disorder (PTST)

Indexed keywords

HISTONE;

ALZHEIMER DISEASE; HISTONE ACETYLATION; HUMAN; MEMORY CONSOLIDATION; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; REVIEW;

EID: 84904999040     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00160     Document Type: Review

References (89)

1. Abel, T., and Zukin, R. S. (2008). Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 8, 57-64. doi: 10.1016/j.coph.2007.12.002
2. Adshead, G. (2000). Psychological therapies for post-traumatic stress disorder. Br. J. Psychiatry 177, 144-148. doi: 10.1192/bjp.177.2.144
3. Agis-Balboa, R. C., Pavelka, Z., Kerimoglu, C., and Fischer, A. (2013). Loss of HDAC5 impairs memory function: implications for Alzheimer's disease. J. Alzheimers. Dis. 33, 35-44. doi: 10.3233/JAD-2012-121009
4. Alarcon, J. M., Malleret, G., Touzani, K., Vronskaya, S., Ishii, S., Kandel, E. R., et al. (2004). Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42, 947-959. doi: 10.1016/j.neuron.2004.05.021
5. Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwein, T., Kouzarides, T., et al. (2007). New nomenclature for chromatin-modifying enzymes. Cell 131, 633-636. doi: 10.1016/j.cell.2007.10.039
6. Bahari-Javan, S., Maddalena, A., Kerimoglu, C., Wittnam, J., Held, T., Bähr, M., et al. (2012). HDAC1 regulates fear extinction in mice. J. Neurosci. 32, 5062-5073. doi: 10.1523/JNEUROSCI.0079-12.2012
7. Barrett, R. M., Malvaez, M., Kramar, E., Matheos, D. P., Arrizon, A., Cabrera, S. M., et al. (2011). Hippocampal focal knockout of CBP affects specific histone modifications, long-term potentiation, and long-term memory. Neuropsychopharmacology 36, 1545-1556. doi: 10.1038/npp.2011.61
8. Bateman, R. J., Xiong, C., Benzinger, T. L., Fagan, A. M., Goate, A., Fox, N. C., et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795-804. doi: 10.1056/NEJMoa1202753
9. Bisson, J., and Andrew, M. (2007). Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst. Rev. 18:CD003388. doi: 10.1002/14651858.CD003388
10. Bredy, T. W., and Barad, M. (2008). The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. Learn. Mem. 15, 39-45. doi: 10.1101/lm.801108
11. Bredy, T. W., Wu, H., Crego, C., Zellhoefer, J., Sun, Y. E., and Barad, M. (2007). Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn. Mem. 14, 268-276. doi: 10.1101/lm.500907
12. Burri, A., Maercker, A., Krammer, S., and Simmen-Janevska, K. (2013). Childhood trauma and PTSD symptoms increase the risk of cognitive impairment in a sample of former indentured child laborers in old age. PLoS ONE 8:e57826. doi: 10.1371/journal.pone.0057826
13. Chatterjee, S., Mizar, P., Cassel, R., Neidl, R., Selvi, B. R., Mohankrishna, D. V., et al. (2013). A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice. J. Neurosci. 33, 10698-10712. doi: 10.1523/JNEUROSCI.5772-12.2013
14. Chen, G., Zou, X., Watanabe, H., van Deursen, J. M., and Shen, J. (2010). CREB binding protein is required for both short-term and long-term memory formation. J. Neurosci. 30, 13066-13070. doi: 10.1523/JNEUROSCI.2378-10.2010
15. Cruz, J. C., Kim, D., Moy, L. Y., Dobbin, M. M., Sun, X., Bronson, R. T., et al. (2006). p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J. Neurosci. 26, 10536-10541. doi: 10.1523/JNEUROSCI.3133-06.2006
16. Cruz, J. C., Tseng, H. C., Goldman, J. A., Shih, H., and Tsai, L. H. (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483. doi: 10.1016/S0896-6273(03)00627-5
17. Day, J. J., and Sweatt, J. D. (2010). DNA methylation and memory formation. Nat. Neurosci. 13, 1319-1323. doi: 10.1038/nn.2666
18. Deacon, B. J., and Abramowitz, J. S. (2004). Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings. J. Clin. Psychol. 60, 429-441. doi: 10.1002/jclp.10255
19. Domschke, K. (2012). Patho-genetics of posttraumatic stress disorder. Psychiatr. Danub. 24, 267-273.
20. Fischer, A., Sananbenesi, F., Mungenast, A., and Tsai, L. H. (2010). Targeting the right HDAC(s) to treat congitive diseases. Trends Pharmacol. Sci. 31, 605-617. doi: 10.1016/j.tips.2010.09.003
21. Fischer, A., Sananbenesi, F., Pang, P. T., Lu, B., and Tsai, L. H. (2005). Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48, 825-838. doi: 10.1016/j.neuron.2005.10.033
22. Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., and Tsai, L. H. (2007). Recovery of learning & memory after neuronal loss is associated with chromatin remodeling. Nature 447, 178-182. doi: 10.1038/nature05772
23. Fischer, A., and Tsai, L. H. (2008). "Counteracting molecular pahtways regulating the reduction fo fear: implications for the treatment of anxiety diseases," in Post Traumatic Stress Disorders Basic Science and Clinical Disorder, eds P. J. Shiromani, T. M. Keane, and J. E. LeDouxand (New York, NY: Humana Press), 79-103.
24. Fontán-Lozano, A., Romero-Granados, R., Troncoso, J., Múnera, A., Delgado-García, J. M., and Carrión, A. M. (2008). Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice. Mol. Cell. Neurosci. 39, 193-201. doi: 10.1016/j.mcn.2008.06.009
25. Francis, Y. I., Fà, M., Ashraf, H., Zhang, H., Staniszewski, A., Latchman, D. S., et al. (2009). Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. J. Alzheimers Dis. 18, 131-139. doi: 10.3233/JAD-2009-1134
26. Fujita, Y., Morinobu, S., Takei, S., Fuchikami, M., Matsumoto, T., Yamamoto, S., et al. (2012). Vorinostat, a histone deacetylase inhibitor, facilitates fear extinction and enhances expression of the hippocampal NR2B-containing NMDA receptor gene. J. Psychiatr. Res. 46, 635-643. doi: 10.1016/j.jpsychires.2012.01.026
27. Goate, A., and Hardy, J. (2012). Twenty years of Alzheimer's disease-causing mutations. J. Neurochem. 120, 3-8. doi: 10.1111/j.1471-4159.2011.07575.x
28. Govindarajan, N., Agis-Balboa, C., Walter, J., Sananbenesi, F., and Fischer, A. (2011). Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. J. Alzheimers Dis. 24, 1-11. doi: 10.3233/JAD-2011-110080
29. Govindarajan, N., Rao, P., Burkhardt, S., Sananbenesi, F., Schlüter, O. M., Bradke, F., et al. (2013). Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease. EMBO Mol. Med. 5, 52-63. doi: 10.1002/emmm.201201923
30. Gräff, J., Rei, D., Guan, J. S., Wang, W. Y., Seo, J., Hennig, K. M., et al. (2012). An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483, 7388. doi: 10.1038/nature10849
31. Guan, J. S., Haggarty, S. J., Giacometti, E., Dannenberg, J. H., Joseph, N., Gao, J., et al. (2009). HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55-60. doi: 10.1038/nature07925
32. Haass, C., and Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 112-116. doi: 10.1038/nrm2101
33. Heinrichs, S. C., Leite-Morris, K. A., Rasmusson, A. M., and Kaplan, G. B. (2013). Repeated valproate treatment facilitates fear extinction under specific stimulus conditions. Neurosci. Lett. 552, 108-113. doi: 10.1016/j.neulet.2013.07.035
34. Holliday, R. (1994). Epigenetics: an overview. Dev. Genet. 15, 453-457. doi: 10.1002/dvg.1020150602
35. Host, L., Dietrich, J. B., Carouge, D., Aunis, D., and Zwiller, J. (2011). Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. J. Psychopharmacol. 25, 222-229. doi: 10.1177/0269881109348173
36. Jakovcevski, M., and Akbarian, S. (2012). Epigenetic mechanisms in neurological disease. Nat. Med. 18, 1194-1204. doi: 10.1038/nm.2828
37. Jordi, E., Heiman, M., Marion-Poll, L., Guermonprez, P., Cheng, S. K., Nairn, A. C., et al. (2013). Differential effects of cocaine on histone posttranslational modifications in identified populations of striatal neurons. Proc. Natl. Acad. Sci. U.S.A. 110, 9511-9516. doi: 10.1073/pnas.1307116110
38. Kilgore, M., Miller, C. A., Fass, D. M., Hennig, K. M., Haggarty, S. J., Sweatt, J. D., et al. (2010). Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35, 870-880. doi: 10.1038/npp.2009.197
39. Kim, M. S., Akhtar, M. W., Adachi, M., Mahgoub, M., Bassel-Duby, R., Kavalali, E. T., et al. (2012). An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J. Neurosci. 32, 10879-10886. doi: 10.1523/JNEUROSCI.2089-12.2012
40. Kim, T., Park, J. K., Kim, H. J., Chung, J. H., and Kim, J. W. (2010). Association of histone deacetylase genes with schizophrenia in Korean population. Psychiatry Res. 178, 266-269. doi: 10.1016/j.psychres.2009.05.007
41. Korzus, E., Rosenfeld, M. G., and Mayford, M. (2004). CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42, 961-972. doi: 10.1016/j.neuron.2004.06.002
42. Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705. doi: 10.1016/j.cell.2007.02.005
43. Kumar, A., Choi, K. H., Renthal, W., Tsankova, N. M., Theobald, D. E., Truong, H. T., et al. (2005). Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48, 303-314. doi: 10.1016/j.neuron.2005.09.023
44. Lattal, K. M., Barrett, R. M., and Wood, M. A. (2007). Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav. Neurosci. 121, 1125-1131. doi: 10.1037/0735-7044.121.5.1125
45. Lee, K. K., and Workman, J. L. (2007). Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 8, 285-295. doi: 10.1038/nrm2145
46. Lee, R. S., Tamashiro, K. L., Aryee, M. J., Murakami, P., Seifuddin, F., Herb, B., et al. (2011). Adaptation of the CHARM DNA methylation platform for the rat genome reveals novel brain region-specific differences. Epigenetics 6, 1378-1390. doi: 10.4161/epi.6.11.18072
47. Levenson, J. M., O'Riordan, K. J., Brown, K. D., Trinh, M. A., Molfese, D. L., and Sweatt, J. D. (2004). Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem. 279, 40545-40559. doi: 10.1074/jbc.M402229200
48. Lopez-Atalaya, J. P., Ito, S., Valor, L. M., Benito, E., and Barco, A. (2013). Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition. Nucleic Acids Res. 41, 8072-8084. doi: 10.1093/nar/gkt590
49. Maddox, S. A., Schafe, G. E., and Ressler, K. J. (2013). Exploring epigenetic regulation of fear memory and biomarkers associated with post-traumatic stress disorder. Front. Psychiatry 4:62. doi: 10.3389/fpsyt.2013.00062
50. Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., and Kivipelto, M. (2010). Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 9, 702-716. doi: 10.1016/S1474-4422(10)70119-8
51. Matsumoto, Y., Morinobu, S., Yamamoto, S., Matsumoto, T., Takei, S., Fujita, Y., et al. (2013). Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder. Psychopharmacology (Berl) 229, 51-62. doi: 10.1007/s00213-013-3078-9
52. Maurice, T., Duclot, F., Meunier, J., Naert, G., Givalois, L., Meffre, J., et al. (2008). Altered memory capacities and response to stress in p300/CBP-associated factor (PCAF) histone acetylase knockout mice. Neuropsychopharmacology 33, 1584-1602. doi: 10.1038/sj.npp.1301551
53. McNulty, S. E., Barrett, R. M., Vogel-Ciernia, A., Malvaez, M., Hernandez, N., Davatolhagh, M. F., et al. (2012). Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory. Learn. Mem. 19, 588-592. doi: 10.1101/lm.026385.112
54. McQuown, S. C., Barrett, R. M., Matheos, D. P., Post, R. J., Rogge, G. A., Alenghat, T., et al. (2011). HDAC3 is a critical negative regulator of long-term memory formation. J. Neurosci. 31, 764-774. doi: 10.1523/JNEUROSCI.5052-10.2011
55. Morris, M. J., Mahgoub, M., Na, E. S., Pranav, H., and Monteggia, L. M. (2013). Loss of histone deacetylase 2 improves working memory and accelerates extinction learning. J. Neurosci. 33, 6401-6411. doi: 10.1523/JNEUROSCI.1001-12.2013
56. Myers, K. M., and Davis, M. (2007). Mechanisms of fear extinction. Mol. Psychiatry 12, 120-150. doi: 10.1038/sj.mp.4001939
57. Oliveira, A. M., Wood, M. A., McDonough, C. B., and Abel, T. (2007). Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits. Learn. Mem. 14, 564-572. doi: 10.1101/lm.656907
58. Palop, J. J., and Mucke, L. (2010). Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 13, 812-818. doi: 10.1038/nn.2583
59. Park, C. S., Rehrauer, H., and Mansuy, I. M. (2013). Genome-wide analysis of H4K5 acetylation associated with fear memory in mice. BMC Genomics 8:539. doi: 10.1186/1471-2164-14-539
60. Parkel, S., Lopez-Atalaya, J. P., and Barco, A. (2013). Histone H3 lysine methylation in cognition and intellectual disability disorders. Learn. Mem. 20, 570-579. doi: 10.1101/lm.029363.112
61. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L. H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622. doi: 10.1038/45159
62. Peleg, S., Sananbenesi, F., Zovoilis, A., Burkhardt, S., Bahari-Java, S., Agis-Balboa, R. C., et al. (2010). Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328, 753-756. doi: 10.1126/science.1186088
63. Ponomarev, I., Rau, V., Eger, E. I., Harris, R. A., and Fanselow, M. S. (2010). Amygdala transcriptome and cellular mechanisms underlying stress-enhanced fear learning in a rat model of posttraumatic stress disorder. Neuropsychopharmacology 35, 1402-1411. doi: 10.1038/npp.2010.10
64. Reolon, G. K., Maurmann, N., Werenicz, A., Garcia, V. A., Schröder, N., Wood, M. A., et al. (2011). Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats. Behav. Brain Res. 221, 329-332. doi: 10.1016/j.bbr.2011.03.033
65. Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., et al. (2004). Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch. Gen. Psychiatry 61, 1136-1144. doi: 10.1001/archpsyc.61.11.1136
66. Ricobaraza, A., Cuadrado-Tejedor, M., Marco, S., Pérez-Otaño, I., and García-Osta, A. (2010). Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 22, 1040-1050. doi: 10.1002/hipo.20883
67. Ricobaraza, A., Cuadrado-Tejedor, M., Pérez-Mediavilla, A., Frechilla, D., Del Río, J., and García-Osta, A. (2009). Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 34, 1721-1732. doi: 10.1038/npp.2008.229
68. Rudenko, A., and Tsai, L. H. (2014). Epigenetic modifications in the nervous system and their impact upon cognitive impairments. Neuropharmacology 80, 70-82. doi: 10.1016/j.neuropharm.2014.1001.1043
69. Rusiecki, J. A., Chen, L., Srikantan, V., Zhang, L., Yan, L., Polin, M. L., et al. (2012). DNA methylation in repetitive elements and post-traumatic stress disorder: a case-control study of US military service members. Epigenomics 4, 29-40. doi: 10.2217/epi.11.116
70. Sananbenesi, F., and Fischer, A. (2009). The epigenetic bottleneck of neurodegenerative and psychiatric diseases. Biol. Chem. 390, 1145-1153. doi: 10.1515/BC.2009.131
71. Sananbenesi, F., Fischer, A., Wang, X., Schrick, C., Neve, R., Radulovic, J., et al. (2007). A hippocampal Cdk5 pathway regulates extinction of contextual fear. Nat. Neurosci. 10, 1012-1019. doi: 10.1038/nn1943
72. Sando, R. 3rd. Gounko, N., Pieraut, S., Liao, L., Yates, J. 3rd., and Maximov, A. (2012). HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 151, 821-834. doi: 10.1016/j.cell.2012.09.037
73. Schmitt, M., and Matthies, H. (1979). Biochemical studies on histones of the central nervous system. III. Incorporation of [14C]-acetate into the histones of different rat brain regions during a learning experiment. Acta Biol. Med. Ger. 38, 683-689.
74. Schneider, A., Chatterjee, S., Bousiges, O., Selvi, B. R., Swaminathan, A., Cassel, R., et al. (2013). Acetyltransferases (HATs) as targets for neurological therapeutics. Neurotherapeutics 10, 569-588. doi: 10.1007/s13311-013-0204-7
75. Selvi, B. R., Cassel, J. C., Kundu, T. K., and Boutillier, A. L. (2010). Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases. Biochim. Biophys. Acta 1799, 840-853. doi: 10.1016/j.bbagrm.2010.08.012
76. Snowdon, D. A., Greiner, L. H., Mortimer, J. A., Riley, K. P., Greiner, P. A., and Markesbery, W. R. (1997). Brain infarction and the clinical expression of Alzheimer's disease. The nun study. JAMA 277, 813-817. doi: 10.1001/jama.1997.03540340047031
77. Sotres-Bayon, F., Cain, C. K., and LeDoux, J. E. (2006). Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol. Psychiatry 60, 329-336. doi: 10.1016/j.biopsych.2005.10.012
78. Strahl, B. D., and Allis, C. D. (2000). The language of covalent histone modifications. Nature 403, 41-45. doi: 10.1038/47412
79. Sung, Y. M., Lee, T., Yoon, H., DiBattista, A. M., Song, J., Sohn, Y., et al. (2013). Mercaptoacetamide-based class II HDAC inhibitor lowers Aß levels and improves learning and memory in a mouse model of Alzheimer's disease. Exp. Neurol. 239, 192-201. doi: 10.1016/j.expneurol.2012.10.005
80. Uddin, M., Aiello, A. E., Wildman, D. E., Koenen, K. C., Pawelec, G., de Los Santos, R., et al. (2010). Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proc. Natl. Acad. Sci. U.S.A. 107, 9470-9475. doi: 10.1073/pnas.0910794107
81. Vaquero, A., Loyola, A., and Reinberg, D. (2003). The constantly changing face of chromatin. Sci. Aging Knowledge Environ. 14:RE4. doi: 10.1126/sageke.2003.14.re4
82. Vecsey, C. G., Hawk, J. D., Lattal, K. M., Stein, J. M., Fabian, S. A., Attner, M. A., et al. (2007). Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J. Neurosci. 27, 6128-6140. doi: 10.1523/JNEUROSCI.0296-07.2007
83. Wang, W. H., Cheng, L. C., Pan, F. Y., Xue, B., Wang, D. Y., Chen, Z., et al. (2011). Intracellular trafficking of histone deacetylase 4 regulates long-term memory formation. Anat. Rec (Hoboken). 294, 1025-1034. doi: 10.1002/ar.21389
84. Whittle, N., Schmuckermair, C., Gunduz Cinar, O., Hauschild, M., Ferraguti, F., Holmes, A., et al. (2013). Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model. Neuropharmacology 64, 414-423. doi: 10.1016/j.neuropharm.2012.06.001
85. Williams, S. R., Aldred, M. A., Der Kaloustian, V. M., Halal, F., Gowans, G., McLeod, D. R., et al. (2010). Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am. J. Hum. Genet. 87, 219-228. doi: 10.1016/j.ajhg.2010.07.011
86. Wood, M. A., Attner, M. A., Oliveira, A. M., Brindle, P. K., and Abel, T. (2006). A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn. Mem. 13, 609-617. doi: 10.1101/lm.213906
87. Yaffe, K., Vittinghoff, E., Lindquist, K., Barnes, D., Covinsky, K. E., Nylan, T., et al. (2010). Posttraumatic stress disorder and risk of dementia among US veterans. Arch. Gen. Psychiatry 67, 608-613. doi: 10.1001/archgenpsychiatry.2010.61
88. Zhang, Z. Y., and Schluesener, H. J. (2013). Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model. J. Neuropathol. Exp. Neurol. 72, 178-185. doi: 10.1097/NEN.0b013e318283114a
89. Zovkic, I. B., Meadows, J. P., Kaas, G. A., and Sweatt, J. D. (2013). Interindividual variability in stress susceptibility: a role for epigenetic mechanisms in PTSD. Front. Psychiatry 4:60. doi: 10.3389/fpsyt.2013.00060